Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Cartilage turnover reflected by metabolic processing of type II collagen: a novel marker of anabolic function in chondrocytes

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. New Aspects of the Kidney in the Regulation of Fibroblast Growth Factor 23 (FGF23) and Mineral Homeostasis

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  2. Age-Associated Salivary MicroRNA Biomarkers for Oculopharyngeal Muscular Dystrophy

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Genetic Biomarkers in Melanoma of the Ocular Region: What the Medical Oncologist Should Know

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  4. Exercise Oncology and Immuno-Oncology; A (Future) Dynamic Duo

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  1. Potential diagnostic value of a type X collagen neo-epitope biomarker for knee osteoarthritis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Cementless metaphyseal sleeves without stem in revision total knee arthroplasty

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. The effect of protease inhibitors on the induction of osteoarthritis-related biomarkers in bovine full-depth cartilage explants

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. The active form of MMP-3 is a marker of synovial inflammation and cartilage turnover in inflammatory joint diseases

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Karoline Natasja Stæhr Gudmann
  • Jianxia Wang
  • Sabine Hoielt
  • Pingping Chen
  • Anne Sofie Siebuhr
  • Yi He
  • Thorbjørn G Christiansen
  • Morten Asser Karsdal
  • Anne Christine Bay-Jensen
Vis graf over relationer

The aim of this study was to enable measurement of cartilage formation by a novel biomarker of type II collagen formation. The competitive enzyme-linked immunosorbent assay (ELISA) Pro-C2 was developed and characterized for assessment of the beta splice variant of type II procollagen (PIIBNP). This is expected to originate primarily from remodeling of hyaline cartilage. A mouse monoclonal antibody (Mab) was raised in mouse, targeting specifically PIIBNP (QDVRQPG) and used in development of the assay. The specificity, sensitivity, 4-parameter fit and stability of the assay were tested. Levels of PIIBNP were quantified in human serum (0.6-2.2 nM), human amniotic fluid (163-188 nM) and sera from different animal species, e.g., fetal bovine serum (851-901 nM) with general good linearity (100% (SD 7.6) recovery) and good intra- and inter-assay variation (CV% < 10). Dose (0.1 to 100 ng/mL) and time (7, 14 and 21 days) dependent release of PIIBNP were evaluated in the conditioned medium from bovine cartilage explants (BEX) and human cartilage explants (HEX) upon stimulation with insulin-like growth factor (IGF-1), transforming growth factor (TGF)-β1 and fibroblastic growth factor-2 (FGF-2). TGF-β1 and IGF-1 in concentrations of 10-100 ng/mL significantly (p < 0.05) induced release of PIIBNP in BEX compared to conditions without treatment (WO). In HEX, IGF-1 100 ng/mL was able to induce a significant increase of PIIBNP after one week compared to WO. FGF-2 did not induce a PIIBNP release in our models. To our knowledge this is the first assay, which is able to specifically evaluate PIIBNP excretion. The Pro-C2 assay seems to provide a promising and novel marker of type II collagen formation.

OriginalsprogEngelsk
TidsskriftInternational Journal of Molecular Sciences (Online)
Vol/bind15
Udgave nummer10
Sider (fra-til)18789-803
Antal sider15
ISSN1422-0067
DOI
StatusUdgivet - 2014

ID: 45108229